Literature DB >> 16441418

Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion.

Kaoru Miyazaki1.   

Abstract

The development and progression of tumor cells is controlled by their interactions with neighboring host cells and a variety of microenvironmental factors including extracellular matrix (ECM) molecules, growth factors and proteinases. Cell-adhesive ECM proteins are a prerequisite for growth and migration of many types of cells. Their interactions with integrins and other cell surface receptors induce intracellular signaling that regulates the actin cytoskeleton and gene expression. The basement membrane protein laminin-5 is a notable cell adhesion molecule, which promotes cellular adhesion and migration much more efficiently than other ECM proteins. There is accumulating evidence that laminin-5 is involved in tumor growth and progression. With special reference to laminin-5, this article reviews the regulatory mechanisms of cellular adhesion and migration by ECM molecules and their significance in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441418     DOI: 10.1111/j.1349-7006.2006.00150.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  64 in total

Review 1.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

2.  The effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell.

Authors:  Hong Song; Yun-Zhu Han; Guo-Hui Cai; Fu-Shan Tang; Ze-Hong Yang; Di-Shu Ao; An Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain.

Authors:  Takashi Ogawa; Yoshiaki Tsubota; Junko Hashimoto; Yoshinobu Kariya; Kaoru Miyazaki
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

Review 4.  Laminin isoforms in development and disease.

Authors:  Susanne Schéele; Alexander Nyström; Madeleine Durbeej; Jan F Talts; Marja Ekblom; Peter Ekblom
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 5.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Micropatterned dermal-epidermal regeneration matrices create functional niches that enhance epidermal morphogenesis.

Authors:  Amanda L Clement; Thomas J Moutinho; George D Pins
Journal:  Acta Biomater       Date:  2013-08-17       Impact factor: 8.947

7.  The influence of substrate topography on the migration of corneal epithelial wound borders.

Authors:  Bernardo Yanez-Soto; Sara J Liliensiek; Joshua Z Gasiorowski; Christopher J Murphy; Paul F Nealey
Journal:  Biomaterials       Date:  2013-09-07       Impact factor: 12.479

8.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

9.  N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.

Authors:  Yoshinobu Kariya; Rika Kato; Satsuki Itoh; Tomohiko Fukuda; Yukinao Shibukawa; Noriko Sanzen; Kiyotoshi Sekiguchi; Yoshinao Wada; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

10.  Localization of laminin alpha3B chain in vascular and epithelial basement membranes of normal human tissues and its down-regulation in skin cancers.

Authors:  Yoshinobu Kariya; Taizo Mori; Chie Yasuda; Naoko Watanabe; Yoshie Kaneko; Yukiko Nakashima; Takashi Ogawa; Kaoru Miyazaki
Journal:  J Mol Histol       Date:  2008-08-01       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.